WSJ - US News · Wednesday, May 6, 2026 — 8:36 AM ET
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
HeadlineDispatch groups this story with the Economy, Politics cluster so readers can move from the headline to related coverage without losing the thread.